Megan Hoban
Company: Orna Therapeutics
Job title: Senior Director, Program Lead
Seminars:
Chair’s Closing Remarks 3:15 pm
day: Conference Day Two
In Vivo Cell Engineering using oRNA® 2:15 pm
Orna is leveraging its groundbreaking circular RNA technology paired with its extensive LNP delivery platform to enable the next generation of in vivo cell therapies Featuring robust delivery of oRNA to immune cells enabling in vivo CAR mediated depletion of target B cells in vivo Demonstrating key progress showing in vivo editing of hematopoietic stem…Read more
day: Conference Day Two
Panel Discussion: Addressing the Safety of Delivery in the In Vivo CAR-T Space 1:00 pm
Navigating the safety of delivery mechanisms to collaborate in ensuring vectors are as safe as possible Clarifying the latest FDA guidelines in the ex vivo CAR-T space to apply insights to the in vivo space Evaluating how this may impact in vivo pipelines using viral vectors to plan for the futureRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day Two